Page title

Medication Assisted Treatment – Prescription Drug and Opioid Addiction

Description

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2021 Medication-Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder (OUD) seeking or receiving MAT. The desired outcomes for this program are: 1) an increase in the number of individuals with OUD receiving MAT; and 2) a decrease in illicit opioid drug use and prescription opioid misuse at six-month follow-up.

Eligibility

Eligible applicants are domestic public and private non-profit entities.

Award Information

Funding Mechanism: Grant

Anticipated Total Available Funding: $71,322,952 (At least $11 million will be awarded to federally recognized tribes/tribal organizations)

Anticipated Number of Awards: 89 – 135 awards

Anticipated Award Amount: Up to $1 million per year for states and up to $525,000 per year for other domestic public or non-profit entities.

Length of Project: Up to 5 years

Cost Sharing/Match Required?: No

Proposed budgets cannot exceed $1,000,000 for states in total costs (direct and indirect) in any year of the proposed project. Proposed budgets cannot exceed $525,000 for territories, federally recognized tribes and tribal organizations, and other domestic public or non-profit entities in total costs (direct and indirect) in any year of the proposed project. Annual continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.